获取途径

作者

Zhang W Zhao D Meng Z Wang H Zhao K Feng X Li Y Dun A Jin X Hou H

作者单位

Yingsheng East Road, Taian, 271000, People's Republic of China. 8812695@qq.com. Yingsheng East Road, Taian, 271000, People's Republic of China. hfhou@16 School of Public Health, Taishan Medical University, Yingsheng East Road, Taian, 271000, People's Republic of China. das1977@16 School of Medical and Health Sciences, Edith Cowan University, Perth, 6027, Australia. hfhou@16 Yingsheng East Road, Taian, 271000, People's Republic of China. School of Basic Medical Science, Taishan Medical University, Affiliated Hospital, Taishan Medical University, Taian, 271000, People's Republic of China. com.

刊名

Acta Diabetologica

年份

2018

ISSN

0940-5429

关键词

Body mass index Gestational diabetes mellitus Visfatin

分类号

616.462

摘要

Aims: Gestational diabetes mellitus is a medical complication of any degree of glucose intolerance with onset or first recognition during pregnancy. Although visfatin is commonly considered to be related to GDM, studies revealed inconsistent results. This study aimed to clarify the relationship between visfatin and GDM. Methods: The protocol for this study was registered in PROSPERO in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses . PubMed and Embase da...更多

Aims: Gestational diabetes mellitus is a medical complication of any degree of glucose intolerance with onset or first recognition during pregnancy. Although visfatin is commonly considered to be related to GDM, studies revealed inconsistent results. This study aimed to clarify the relationship between visfatin and GDM. Methods: The protocol for this study was registered in PROSPERO in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses . PubMed and Embase databases were used to search for relevant studies published up to September 30, 2017. The difference of visfatin levels between women with GDM and the controls was measured by standardised mean difference and 95% confidence interval . Results: Twenty-six studies that were published in 24 articles met the inclusion criteria, in which 2305 participants were included. The quantitative meta-analysis revealed no significant difference in circulating visfatin levels between women with GDM and the controls . Subgroup analyses were performed referring to body mass index where inconsistent results have been observed between cases and controls groups. For the ten studies, in which the level of BMI in women with GDM was higher than that in the control group, the pooled result showed that circulating visfatin was significantly higher among women with GDM than the controls . Of other 16 studies BMI-matched, the pooled SMD illustrated no difference of visfatin. Conclusions: Our study elucidates that visfatin is not independently associated with GDM. Visfatin is linked to GDM through maternal overweight/obesity, which is one of the major factors leading to the development of GDM.收起

学科

【SCI学科】ENDOCRINOLOGY & METABOLISM 【ESI学科】BIOLOGY & BIOCHEMISTRY

影响因子

2016年:3.34;2015年:3.074;2014年:2.399;2013年:3.679;2012年:4.631

文献类型

期刊

浏览量

16